Occludin inhibitors represent a diverse set of chemical compounds that modulate the activity or localization of occludin, a protein vital to the formation and maintenance of tight junctions in cellular layers. Tight junctions are multiprotein complexes that function as barriers between the cells in epithelial and endothelial tissues, controlling the paracellular passage of ions and small molecules. Occludin is one of the key constituents of these junctions and plays a critical role in the assembly, stability, and regulation of these complex structures. Inhibitors of occludin act by affecting either the protein directly or the cellular pathways that control its phosphorylation, localization, or incorporation into the tight junctions. These inhibitors are often used in academic research to help unravel the biological functions and regulatory mechanisms involving tight junctions.
The chemical classes of occludin inhibitors are varied, reflecting their diverse mechanisms of action. These can include small organic molecules, ions, and naturally occurring compounds. For example, some inhibitors such as ethanol act by altering the lipid bilayer fluidity, which in turn affects occludin localization and function. Others like EGTA chelate extracellular calcium ions, essential for the stability of tight junctions. Several kinase inhibitors like wortmannin or LY294002 target the intracellular signaling pathways that control the phosphorylation status and thus the activity of occludin.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $21.00 $65.00 $120.00 $251.00 $815.00 | 23 | |
EGTA chelates extracellular calcium, which is essential for the formation and maintenance of tight junctions, including the function of occludin. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is primarily a calcium channel blocker but also disrupts tight junctions by altering calcium-dependent interactions, including those involving occludin. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin can induce the down-regulation of occludin by initiating cellular stress and apoptotic signaling, thereby compromising the integrity of tight junctions. | ||||||
Heparin | 9005-49-6 | sc-507344 | 25 mg | $119.00 | 1 | |
Heparin disrupts tight junctions including occludin, possibly by competing with extracellular divalent cations required for junction integrity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin disrupts tight junctions by inhibiting protein kinase pathways that regulate the assembly and disassembly of occludin. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, affecting multiple signaling pathways that lead to the disassembly of tight junctions, including the removal of occludin. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a protein kinase inhibitor that can affect occludin phosphorylation, leading to tight junction disassembly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor affecting signaling pathways that regulate the localization and expression of occludin, thereby affecting tight junction integrity. | ||||||